Strategies to Treat Obesity in Patients With CKD
Authors:
- 1 March 2021
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 77 (3) , 427-439
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 99 references indexed in Scilit:
- Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2020
- Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017-2018.2020
- Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored By American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society For Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of AnesthesiologistsEndocrine Practice, 2019
- Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2019
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2019
- Bariatric surgery is associated with improvement in kidney outcomesKidney International, 2016
- Effect of Exercise Training on Estimated GFR, Vascular Health, and Cardiorespiratory Fitness in Patients With CKD: A Pilot Randomized Controlled TrialAmerican Journal of Kidney Diseases, 2015
- Effects of weight loss on renal function in obese CKD patients: a systematic reviewNephrology Dialysis Transplantation, 2013
- Appropriate body-mass index for Asian populations and its implications for policy and intervention strategiesThe Lancet, 2004
- Effects of Body-Weight Loss and Captopril Treatment on Proteinuria Associated with ObesityNephron, 1995